Trilateral retinoblastoma: a case report. by Cho, Eun Yoon et al.
Retinoblastoma (RB) is the most common intraocular
malignancy found in children. It is caused by the inactiva-
tion of both copies of a tumor suppressor gene (Rb1), which
participates in the control of cell cycling (1-3). Approximate-
ly one-third of these tumors are bilateral and is associated
with germinal mutations. All bilateral tumors and one tenth
of unilateral tumors are caused by a germline mutation inher-
ited as an autosomal dominant trait (4, 5). This hereditary
predisposition to retinoblastoma is caused by mutant alleles
occurring at the q14 band of chromosome 13 (6). The asso-
ciation of bilateral RB with ectopic midline intracranial
tumors, termed  “trilateral” retinoblastoma (TRB), is a well
recognized but uncommon syndrome. The association of
ocular RB with brain tumors was first reported in 1971 (7).
The intracranial tumor arises most often in the pineal region
but can also be a suprasellar or parasellar tumor, and is con-
sidered to be an isolated independent primary focus without
evidence of retinal disease. This is the first reported case of
TRB presented with a sellar and suprasellar tumor in
Korea.
CASE REPORT
A 5-month-old female infant presented with poor eye con-
tact and nystagmus for several days. Brain MRI revealed a rel-
atively well circumscribed, lobulated mass, measuring 7.5×
5.7 cm in the sella and suprasella regions (Fig. 1). This mass
showed heterogeneous signal intensity and variable contrast
enhancement in both T1-weighted and T2-weighted images
(Fig. 2). There was permeative growth along the optic gyrus,
but no ocular lesion was found in the preoperative brain MRI.
The brain tumor was partially resected. Pathologic diagno-
sis of intracranial RB was made. Subsequently, with a suspi-
cion of TRB, ophthalmoscopic examination was performed.
It revealed an intraocular whitish subretinal mass, twice the
diameter of a disc on the left eye. No histologic confirmation
was made for the ocular lesion. She did not have a family his-
tory of RB. Postoperatively, the patient received chemother-
apy with cytoxan, vancomycin, and adriamycin. Follow-up
CT of the brain revealed shrinkage of the residual mass in
response to chemotherapy and there was no evidence of meta-
stasis or leptomeningeal spreading. She died of sepsis 6
months thereafter.
Pathologic examination of the removed brain tumor dis-
closed a dense proliferation of small, round, and blue cells
with a high nucleus: cytoplasmic ratio, hyperchromatic nuclei
and some mitoses. Many Flexner-Wintersteiner rosettes and
Homer Wright rosettes were observed (Fig. 3). Calcifications
and necroses were also frequently seen. The tumor showed dif-
Eun Yoon Cho, Yeon-Lim Suh,
Hyung-Jin Shin*
Departments of Diagnostic Pathology and 
Neurosurgery*, Samsung Medical Center,
Sungkyunkwan University School of Medicine,
Seoul, Korea
Address for correspondence
Yeon-Lim Suh, M.D.
Department of Diagnostic Pathology, Samsung
Medical Center, Sungkyunkwan University School
of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul
135-710, Korea
Tel : +82.2-3410-2800, Fax : +82.2-3410-0025
E-mail : ylsuh@smc.samsung.co.kr
137
J Korean Med Sci 2002; 17: 137-40
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Trilateral Retinoblastoma
: A Case Report
Trilateral retinoblastoma is a rare, but well recognized syndrome. These tumors
usually occur in the pineal, parasellar, or suprasellar regions several years after
successful management of ocular retinoblastomas without evidence of direct
extension or distant metastasis. Here we report a case of trilateral retinoblastoma
presenting initially with a sellar tumor and with concurrent unilateral retinoblas-
toma. The patient was a 5-month-old baby girl showing poor eye contact and
nystagmus for several days. She had no family history of retinoblastoma. Brain
MRI revealed a midline suprasellar tumor without evidence of cerebrospinal fluid
seeding or extracranial metastasis. A pathologic diagnosis of retinoblastoma was
made for her brain tumor, and a small, intraocular retinoblastoma was detected
in the left eye by thorough examination of the fundus. If a retinoblastoma occurs
in the midline of the brain, including the pineal and sellar regions, a careful screen-
ing to detect any additional retinal tumors should be performed. Moreover, since
these tumors are often hereditary and harbor a worse prognosis, the diagnosis
has implications for genetic counseling. This is the first report on a case of trilat-
eral retinoblastoma in Korea presented with a sellar mass.
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fuse immunoreactivity for synaptophysin (Fig. 4). Immunos-
tainings for S-100, GFAP, EMA, vimentin, CD99, and colla-
gen IV were all negative. These findings were consistent with
the diagnosis of intracranial RB.
DISCUSSION
TRB is a well-recognized syndrome that is characterized by
unilateral or bilateral hereditary RB in association with a mor-
phologically similar intracranial neoplasm localized in the
Fig. 1. Sagittal view of T1-weighted MRI of the brain. Note a large,
relatively well circumscribed suprasellar mass extending posteri-
orly, displacing the brain stem, as well as into the anterior cranial
fossa.
Fig. 2. Coronal view of contrast-enhanced T2-weighted MRI of
the brain. Slightly heterogeneous enhancement of the suprasellar
mass is noted.
Fig. 3. Histopathologic examination of the intracranial tumor de-
monstrates typical features of retinoblastoma. The small round
tumor cells represent many Flexner-Wintersteiner rosettes (arrow-
heads) with mitotic figures (H&E,×200).
Fig. 4. Note the strong immunoreactivity for neuronal marker (sy-
naptophysin) in the cytoplasms of tumor cells (×200).Trilateral Retinoblastoma 139
pineal gland or the sella or suprasella regions. This case
demonstrated TRB with a sellar and suprasellar mass as well as
unilateral retinoblastoma. TRB with unilateral RB has also
been described as a forme fruste of TRB (8).
The intracranial tumor of TRB arises most often in the
pineal gland but can occur in the suprasellar or parasellar
regions as well. The association between suprasellar tumor and
ocular RBs is referred to as  “sellar” TRB, whereas  “pineal” TRB
is refers to pineal tumor associated with ocular RBs. Bejjani et
al. reported a case of suprasellar mass with intraocular RB,
which showed nearly same presentation as the present case.
The intracranial mass of sellar TRB tends to be the initial
presenting tumor and is diagnosed at a younger age than
the  “pineal” variant since they more readily develop symp-
toms of increased intracranial pressure than pineal variants.
It has a tendency to occur more frequently in females and is
associated more often with unilateral ocular lesions, as is the
case in our patient (9). Although the patients with suprasel-
lar TRB are diagnosed earlier than those with pineal TRB,
their prognosis remains poor and they usually die of metastat-
ic disease or postoperative complications within 10 months
from the diagnosis (10). Three cases of unilateral RB and
sellar tumor without family history has been reported in
English literature since 1977 (9, 11, 12).
Ocular disease in TRB presents much earlier than that in
classic RB with a usual latent period between the diagnosis
of ocular disease and the intracranial lesion (13, 14). As for
our patient, ocular tumor was not discovered in the preop-
erative brain MRI, but was detected postoperatively by the
fundoscopic examination. The ocular mass in this patient
might be a concurrent lesion. According to several studies,
the mean survival in patients with TRB varies from 1 to 28
months after diagnosis of the intracranial lesion and the dis-
ease is almost uniformly fatal with deaths most commonly
due to cerebrospinal metastases (13, 15). In contrast, the 5
yr survival of unilateral ocular RB following adequate treat-
ment is over 90% and slightly less in cases with bilateral
lesions.
In TRB, the retinal tumor is usually small and there is often
no optic nerve involvement, and both of these factors argue
against cerebral metastasis (11, 16). The sellar mass of our
patient can not be considered as a metastasis from the reti-
nal lesion because there was no involvement of the optic
nerve or uveal tract, or extraocular extension, as shown by
ophthalmic examination as well as on MRI.
The ocular RB can extend to the brain by the optic nerve
invasion or by spreading through the cerebrospinal fluid. Typ-
ically, cerebral metastasis represents multiple lesions with sim-
ilar imaging characteristics, and the midline location is unchar-
acteristic of the metastatic lesions: they are also often associat-
ed with skull vault, long bone, and pulmonary metastases.
The present case showed no evidence of cerebrospinal fluid
spreading or hematogenous metastasis.
In addition, metastatic RBs are morphologically different
from primary intracranial RB. They are characterized by
undifferentiated small round cells without Flexner-Winter-
steiner rosettes resembling neuroblastoma, whereas the pri-
mary lesions are morphologically similar to ocular RB. The
histologic findings of this case were similar to those seen in
ocular RB.
It is less likely that this patient may have an ocular metas-
tasis from intracranial retinoblastoma because orbital meta-
static tumors in children are most often of embryonal or un-
differentiated type, such as neuroblastoma, Wilms’ tumor,
and Ewing sarcoma. And orbital metastasis of the intracra-
nial tumors is extremely rare except medulloblastoma.
Most of the theories on the origin of TRB are based on
Knudson’ s proposal, suggesting that two genetic events
( “hits” ) take place, triggering the development of hereditary
RB. The first mutation is inherited and the second muta-
tion, which takes place in the retina, is acquired during life
(17). Bader et al. believed that these two genetic  “hits” are
responsible for the occurrence of intracranial RB, and origi-
nally stated that the  “second primary” tumors are found in
the socalled  “third eye” , the pineal gland (18). There are
two theories that may explain the occurrence of a suprasellar
variant: Susceptibility to RB gene mutation may be shared
by additional cells such as germinal matrix cells in CNS,
since the optic primordia develop from the diencephalon.
The other hypothesis for suprasellar TRB is the occurrence
of tumors from ectopic photoreceptor cells in the sellar area.
This theory is supported by the reports on ectopic retinal
epithelium in an intracranial portion of the optic nerve (11,
19).
Present case has a possibility of congenital intracranial
tumor due to early presentation of 5 months.
The risk of occurrence of RB in siblings of patients with
TRB varies between 1 and 7%, depending on the presence
of a family history (13, 14, 20). Although we must consider
lag time bias, which may be attributable to the time of scre-
ening or the intractability of this tumor, a screening for in-
tracranial disease can be beneficial for children with bilater-
al and hereditary RB. The intraocular lesion in our patient
might have been missed, had it not been for the detailed
examination of the ocular fundus since she had no family
history and the lesion was very small. Careful retinal screen-
ing of patients with ‘sellar’ or other non-pineal RB may
uncover patients with TRB. Since TRB is often hereditary,
the diagnosis has implications for genetic counseling, as
siblings of the patient may also have the disease. The patie-
nts may initially present with a suprasellar tumor or con-
current intraocular RB with suprasellar tumor. The impor-
tance of meticulous search for retinal lesions in children
with parasellar RB is stressed to assure the diagnosis of spo-
radic heritable forms of ‘sellar’ TRB and referral for genetic
counseling.140 E.Y. Cho, Y.-L. Suh, H.-J. Shin
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